First-line treatment of fecal microbiota transplantation for immune-mediated colitis. First-in-human phase I/II safety and preliminary efficacy of PM1032, a bispecific antibody targeting CLDN18.2 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results